Innovazione, la Borsa corre con plastica e super batteri - Corriere.it
Overview of the Italian Primary Markets
Sergio Signore (@signore_sergio) / Twitter
Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases | Journal of Medicinal Chemistry
Relazione sulla Remunerazione MolMed S.p.A.
MolMed: Contact Details and Business Profile
Frontiers | Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer - ScienceDirect
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
MolMed, viaggio nell'officina dei superfarmaci per le terapie geniche - Il Sole 24 ORE
COMUNICATO STAMPA
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
MolMed - YouTube
MolMed - Wikipedia
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK for high-risk leukaemia in the United States
Ultime Notizie Molmed News
I giapponesi di Agc l'anciano un'Opa su Molmed e il titolo corre in borsa
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
L'ok Ue fa volare Molmed (+11%) - MilanoFinanza.it
Will MolMed soon have its first Cell therapy on the Market?
Molmed, l'Opa giapponese in bilico per golden power - ilGiornale.it
Il 2019 è l'anno della svolta per MolMed - MilanoFinanza.it
Will MolMed soon have its first Cell therapy on the Market?
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
